Clinical Trial

Prevalence of Helicobacter Pylori Infection and Gastric Cancer in the West Indies

Study acronym: Hélico-MQ
Recruiting
View on ClinicalTrials.gov →
Summary
Estimating the prevalence of Helicobacter Pylori infection in newly diagnosed stomach cancers in the West-Indies will help to understand the epidemiology of this cancer, which is over-incident in the West Indies compared to France. In addition, the constitution of a biobank (tumor tissues, healthy tissues and serum) will allow to set up in a second time etiological studies to identify other risk factors in particular in connection with the exposure to environmental pollutants to adapt the prevention measures.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2021-06-30; most recent amendment 2026-03-26.
Status change: Not Yet Recruiting → Recruiting 2026-03-26
Trial Details
NCT Number NCT04949737
Lead Sponsor University Hospital Center of Martinique
Conditions Stomach Neoplasms, Gastric Neoplasms, Helicobacter Pylori
Enrollment 112 participants
Start Date 2025-10-09
Primary Completion 2028-04 (estimated)
Study Completion 2028-12 (estimated)
Updated on ClinicalTrials.gov 2026-03-31